Clinical Trials Logo

Scorpion Stings clinical trials

View clinical trials related to Scorpion Stings.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06333834 Not yet recruiting - Clinical trials for Centruroides Envenomation

Assessment of the Efficacy of Scorpion Antivenom Therapy in a Dose-response Manner, in Patients With Scorpionism

Start date: March 30, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

The clinical study aims to compare the effectiveness of applying two different regimens of scorpion antivenom therapy. In the first regimen (control), the medication is administered to all patients, and depending on the severity of the condition, the dosage varies. In the experimental regimen, an identical dose of scorpion antivenom is administered to patients exhibiting signs and symptoms of scorpion sting intoxication, in addition to pain and other symptoms at the sting site. The primary response variable is the time taken for signs and symptoms to resolve, but differences in complications, adverse effects, venom and antivenom concentration in the blood, and the need for other therapeutic measures are also evaluated.

NCT ID: NCT04571411 Not yet recruiting - Scorpion Stings Clinical Trials

Severity of Scorpion Sting in Relation to Hematological Parameters

Start date: December 1, 2020
Phase:
Study type: Observational

The aim of this study is to investigate the relationship between severity of envenomation and hematological parameter by detectig initial mean platelet volume (MPV), neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) in pediatric patients presenting with a scorpion sting.